5,310 reports of this reaction
1.5% of all USTEKINUMAB reports
#10 most reported adverse reaction
PRODUCT USE ISSUE is the #10 most commonly reported adverse reaction for USTEKINUMAB, manufactured by Janssen Biotech, Inc.. There are 5,310 FDA adverse event reports linking USTEKINUMAB to PRODUCT USE ISSUE. This represents approximately 1.5% of all 346,490 adverse event reports for this drug.
USTEKINUMAB has an overall safety score of 78 out of 100. Patients taking USTEKINUMAB who experience product use issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT USE ISSUE is a less commonly reported adverse event for USTEKINUMAB, but still significant enough to appear in the safety profile.
In addition to product use issue, the following adverse reactions have been reported for USTEKINUMAB:
The following drugs have also been linked to product use issue in FDA adverse event reports:
PRODUCT USE ISSUE has been reported as an adverse event in 5,310 FDA reports for USTEKINUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT USE ISSUE accounts for approximately 1.5% of all adverse event reports for USTEKINUMAB, making it a notable side effect.
If you experience product use issue while taking USTEKINUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.